Roth Capital affirms TG Therapeutics (Nasdaq: TGTX) at Focus Pick with target price of $20 following news of a partnership ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE